Literature DB >> 18393801

Epsilon-secretase: reduction of amyloid precursor protein epsilon-site cleavage in Alzheimer's disease.

Fuyuki Kametani1.   

Abstract

The accumulation and deposition of fibrillar Abeta is thought the primary cause of Alzheimer's disease (AD). Abeta is generated by sequential proteolytic processing involving beta- and gamma-secretase on Amyloid beta protein precursor (APP). Recently, gamma-secretase was shown to cleave near the cytoplasmic membrane boundary of APP, called epsilon-site cleavage, as well as in the middle of the membrane domain, called gamma-site cleavage. Recent findings indicate that gamma- and epsilon-site cleavage are regulated independently. In this review, the reduction of epsilon-site cleavage in AD and the importance of epsilon-site cleavage are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18393801     DOI: 10.2174/156720508783954776

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  9 in total

1.  The Longest Amyloid-β Precursor Protein Intracellular Domain Produced with Aβ42 Forms β-Sheet-Containing Monomers That Self-Assemble and Are Proteolyzed by Insulin-Degrading Enzyme.

Authors:  Claire A Krasinski; Qiuchen Zheng; Valerie A Ivancic; Donald E Spratt; Noel D Lazo
Journal:  ACS Chem Neurosci       Date:  2018-08-03       Impact factor: 4.418

Review 2.  Revisiting APP secretases: an overview on the holistic effects of retinoic acid receptor stimulation in APP processing.

Authors:  José J M Vitória; Diogo Trigo; Odete A B da Cruz E Silva
Journal:  Cell Mol Life Sci       Date:  2022-01-28       Impact factor: 9.261

3.  Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus.

Authors:  Daniela Puzzo; Lucia Privitera; Elena Leznik; Mauro Fà; Agnieszka Staniszewski; Agostino Palmeri; Ottavio Arancio
Journal:  J Neurosci       Date:  2008-12-31       Impact factor: 6.167

4.  Endogenous amyloidogenesis in long-term rat hippocampal cell cultures.

Authors:  Sarah J Bertrand; Marina V Aksenova; Micheal Y Aksenov; Charles F Mactutus; Rosemarie M Booze
Journal:  BMC Neurosci       Date:  2011-05-10       Impact factor: 3.288

Review 5.  A window into the heterogeneity of human cerebrospinal fluid Aβ peptides.

Authors:  Roberta Ghidoni; Anna Paterlini; Valentina Albertini; Elena Stoppani; Giuliano Binetti; Kjell Fuxe; Luisa Benussi; Luigi F Agnati
Journal:  J Biomed Biotechnol       Date:  2011-08-23

6.  Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease.

Authors:  Kaan E Biron; Dara L Dickstein; Rayshad Gopaul; Wilfred A Jefferies
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

7.  Amyloid β-mediated Zn2+ influx into dentate granule cells transiently induces a short-term cognitive deficit.

Authors:  Atsushi Takeda; Masatoshi Nakamura; Hiroaki Fujii; Chihiro Uematsu; Tatsuya Minamino; Paul A Adlard; Ashley I Bush; Haruna Tamano
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

Review 8.  Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease.

Authors:  Fuyuki Kametani; Masato Hasegawa
Journal:  Front Neurosci       Date:  2018-01-30       Impact factor: 4.677

Review 9.  MAPK, beta-amyloid and synaptic dysfunction: the role of RAGE.

Authors:  Nicola Origlia; Ottavio Arancio; Luciano Domenici; Shirley ShiDu Yan
Journal:  Expert Rev Neurother       Date:  2009-11       Impact factor: 4.618

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.